Lazard Asset Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.09M Buy
422,785
+323,013
+324% +$3.81M 0.01% 612
2026
Q2
$1.07M Buy
99,772
+23,706
+31% +$183K ﹤0.01% 1203
2026
Q1
$485K Sell
76,066
-11,596
-13% -$80.7K ﹤0.01% 1393
2025
Q4
$617K Buy
87,662
+38,693
+79% +$233K ﹤0.01% 1307
2025
Q3
$269K Buy
+48,969
New +$240K ﹤0.01% 1522
2024
Q2
– Sell
-4,957
Closed -$30K – 2347
2024
Q1
$30K Hold
4,957
– – ﹤0.01% 1803
2023
Q4
$38K Hold
4,957
– – ﹤0.01% 1959
2023
Q3
$34K Buy
4,957
+2,681
+118% +$21.7K ﹤0.01% 1966
2023
Q2
$20K Buy
+2,276
New +$18.9K ﹤0.01% 2101

Other funds holding LFST

Lazard Asset Management's LFST Position: Q3 2026 in Review

Lazard Asset Management increased its Lifestance Health (LFST) stake by 324% in Q3 2026, buying an estimated $3.81M and bringing the position to 422,785 shares worth $5.09M. The position accounts for 0.01% of the portfolio, ranked #612.

Lazard Asset Management first reported a position in LFST in Q2 2023 and has held it in 9 quarters since. 324 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

  • Lazard Asset Management held 422,785 shares of Lifestance Health worth $5.09M as of Q3 2026.
  • Lazard Asset Management bought 323,013 Lifestance Health shares in Q3 2026, an estimated $3.81M.
  • Lifestance Health made up 0.01% of Lazard Asset Management's portfolio in Q3 2026, its #612 holding.
  • Lazard Asset Management first reported a position in Lifestance Health in Q2 2023 and has held it in 9 quarters since.
  • 324 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on Lazard Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.